In this study, PIK3CG was significantly down-regulated in plinabulin-treated group compared with non-treated group, and we first demonstrated that plinabulin was regarded as a novel PIK3CG inhibitor and might be an efficacious anti-cancer agent in glioblastoma treatment. Here, PIK3CG is linked to cancer.